Literature DB >> 18464025

In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism.

M Visser1, J-M Foidart, H J T Coelingh Bennink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18464025     DOI： 10.1080/13697130802050340

Source DB:  PubMed          Journal:  Climacteric        ISSN： 1369-7137            Impact factor:   3.005


× No keyword cloud information.
  12 in total

Review 1.  Treating menopause - MHT and beyond.

Authors:  Susan R Davis; Rodney J Baber
Journal:  Nat Rev Endocrinol       Date:  2022-05-27       Impact factor: 47.564

2.  Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes.

Authors:  Raju Khatri; John K Fallon; Craig Sykes; Natasha Kulick; Rebecca J B Rementer; Taryn A Miner; Amanda P Schauer; Angela D M Kashuba; Kim A Boggess; Kim L R Brouwer; Philip C Smith; Craig R Lee
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

3.  Effects of Estetrol on Migration and Invasion in T47-D Breast Cancer Cells through the Actin Cytoskeleton.

Authors:  Maria Silvia Giretti; Maria Magdalena Montt Guevara; Elena Cecchi; Paolo Mannella; Giulia Palla; Stefania Spina; Guja Bernacchi; Silvia Di Bello; Andrea Riccardo Genazzani; Alessandro D Genazzani; Tommaso Simoncini
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-26       Impact factor: 5.555

4.  Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.

Authors:  Ingrid J M Duijkers; Christine Klipping; Yvette Zimmerman; Nicole Appels; Maud Jost; Catherine Maillard; Marie Mawet; Jean-Michel Foidart; Herjan J T Coelingh Bennink
Journal:  Eur J Contracept Reprod Health Care       Date:  2015       Impact factor: 1.848

5.  Pro-Apoptotic Effects of Estetrol on Long-Term Estrogen-Deprived Breast Cancer Cells and at Low Doses on Hormone-Sensitive Cells.

Authors:  Wei Yue; Carole Verhoeven; Herjan Coelingh Bernnink; Ji-Ping Wang; Richard J Santen
Journal:  Breast Cancer (Auckl)       Date:  2019-05-15

Review 6.  Estetrol and Mammary Gland: Friends or Foes?

Authors:  Anne Gallez; Isabelle Dias Da Silva; Vincent Wuidar; Jean-Michel Foidart; Christel Péqueux
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-08-31       Impact factor: 2.673

Review 7.  A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms.

Authors:  Paru S David; Taryn L Smith; Hannah C Nordhues; Juliana M Kling
Journal:  Int J Womens Health       Date:  2022-03-10

8.  Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer.

Authors:  Anne Gallez; Silvia Blacher; Erik Maquoi; Erika Konradowski; Marc Joiret; Irina Primac; Céline Gérard; Mélanie Taziaux; René Houtman; Liesbet Geris; Françoise Lenfant; Elisabetta Marangoni; Nor Eddine Sounni; Jean-Michel Foidart; Agnès Noël; Christel Péqueux
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

9.  Estetrol Modulates Endothelial Nitric Oxide Synthesis in Human Endothelial Cells.

Authors:  Maria Magdalena Montt-Guevara; Maria Silvia Giretti; Eleonora Russo; Andrea Giannini; Paolo Mannella; Andrea Riccardo Genazzani; Alessandro David Genazzani; Tommaso Simoncini
Journal:  Front Endocrinol (Lausanne)       Date:  2015-07-22       Impact factor: 5.555

10.  The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation.

Authors:  Anne Abot; Coralie Fontaine; Mélissa Buscato; Romain Solinhac; Gilles Flouriot; Aurélie Fabre; Anne Drougard; Shyamala Rajan; Muriel Laine; Alain Milon; Isabelle Muller; Daniel Henrion; Marine Adlanmerini; Marie-Cécile Valéra; Anne Gompel; Céline Gerard; Christel Péqueux; Mélanie Mestdagt; Isabelle Raymond-Letron; Claude Knauf; François Ferriere; Philippe Valet; Pierre Gourdy; Benita S Katzenellenbogen; John A Katzenellenbogen; Françoise Lenfant; Geoffrey L Greene; Jean-Michel Foidart; Jean-François Arnal
Journal:  EMBO Mol Med       Date:  2014-10       Impact factor: 12.137
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.